PPP6C and glioblastoma: The representative PP2A inhibitor, okadaic acid, also inhibits PP6 activity [65], and okadaic acid has a tumor-suppressive effect in GBM cells [55,56], which is likely through suppression of not only PP2A but also PP6 activity.